To the Editor: In human hematopoietic stem and progenitor cells (HSPCs), TP53 mutations characterize clonal hematopoiesis of indeterminate potential (CHIP) and are recognized as a high-risk factor for the development of non-neoplastic and neoplastic disorders, particularly myelodysplastic syndromes (MDS) and acute myeloid leukemia [1, 2].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Albert WÖlfler
Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study | Blood Cancer Journal
|
By Jennifer Moritz, Verena Petzer, Dominik Wolf, Karoline V. Gleixner, Wolfgang R Sperr, Christina Groiss, Sigrid Machherndl-Spandl, Gregor Eisenwort, Elisabeth Koller, Josef Singer, Gudrun Pregartner, Annkristin Heine, Albert WÖlfler, Heinz Sill, Andreas Reinisch, Sonja Wurm, Johannes Schoeche, Clemens Petrasch
|
Nature
Verified
BRAFV600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis - Leukemia
To the Editor: In the last decade, the gain-of-function BRAFV600E mutation was observed to be recurrent in the histiocytic disorders Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD), characterized by the infiltration of CD1a+CD207+ and CD68+CD1a− clonal mononuclear phagocytes, respectively [1].
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities - Leukemia
Abstract Calreticulin (CALR) mutations present the main oncogenic drivers in JAK2 wildtype (WT) myeloproliferative neoplasms (MPN), including essential thrombocythemia and myelofibrosis, where mutant (MUT) CALR is increasingly recognized as a suitable mutation-specific drug target.
Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination
A 51-year-old woman attended our emergency department with a 3-day history of dyspnoea, fatigue, and cough; 11 days earlier she had the ChAdOx1 nCoV-19 vaccination. On examination she was afebrile, her peripheral oxygen saturation was 98% (fraction of inspired O2 21%), blood pressure was 150/90 mm Hg, heart rate was 98 beats per min, and body-mass index was 31 kg/m2.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Albert
Contact Albert, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack